Summary slide.png (125.2 kB)

Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study

figure

posted on 2020-11-02, 09:53 authored by Toshifumi Tada, Takashi Kumada, Hiroaki Okushin, Joji Tani, Koichi Takaguchi, Akemi Tsutsui, Hidenori Toyoda, Satoshi Yasuda, Kazufumi Dohmen, Atsushi Hiraoka, Kojiro Michitaka, Kazuhiro Nouso, Kazuya Kariyama, Soo Ryang Kim, Soo Ki Kim, Shinichi Fujioka, Shigeru Mikami, Yuto Watanabe, Tsutomu Tamai, Masanori Atsukawa, Norio Itokawa, Hironori Tanaka, Kunihiko Tsuji, Toru Ishikawa, Michitaka Imai, Ei Itobayashi, Hiroshi Shibata, Noritomo Shimada

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).